The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jonathan Corren

Research Division

Allergy Medical Clinic

Los Angeles

California 90025

USA

[email]@ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Research Division, Allergy Medical Clinic, Los Angeles, California 90025, USA. 2009 - 2011
  • Allergy Medical Clinic, Research Division, Los Angeles, USA. 2007 - 2011
  • Allergy Research Foundation, University of California, Los Angeles, 11620 Wilshire Boulevard #200, USA. 2008

References

  1. Cytokine inhibition in severe asthma: current knowledge and future directions. Corren, J. Curr. Opin. Pulm. Med (2011) [Pubmed]
  2. Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge. Corren, J., Wood, R.A., Patel, D., Zhu, J., Yegin, A., Dhillon, G., Fish, J.E. J. Allergy Clin. Immunol. (2011) [Pubmed]
  3. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Corren, J., Busse, W., Meltzer, E.O., Mansfield, L., Bensch, G., Fahrenholz, J., Wenzel, S.E., Chon, Y., Dunn, M., Weng, H.H., Lin, S.L. Am. J. Respir. Crit. Care Med. (2010) [Pubmed]
  4. Efficacy and safety of budesonide and formoterol in asthma. Corren, J. Hosp. Pract. (Minneap) (2009) [Pubmed]
  5. Safety and tolerability of omalizumab. Corren, J., Casale, T.B., Lanier, B., Buhl, R., Holgate, S., Jimenez, P. Clin. Exp. Allergy (2009) [Pubmed]
  6. Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. Corren, J., Lemay, M., Lin, Y., Rozga, L., Randolph, R.K. Nutr. J (2008) [Pubmed]
  7. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy. Corren, J., Shapiro, G., Reimann, J., Deniz, Y., Wong, D., Adelman, D., Togias, A. J. Allergy Clin. Immunol. (2008) [Pubmed]
  8. Small airways disease in asthma. Corren, J. Curr. Allergy. Asthma. Rep (2008) [Pubmed]
  9. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Corren, J., Korenblat, P.E., Miller, C.J., O'Brien, C.D., Mezzanotte, W.S. Clin. Ther (2007) [Pubmed]
 
WikiGenes - Universities